Clinical trial
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced…
NCT00003451 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00003451 |
|---|---|
| Title | Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer |
| Official title | Phase I Trial of Interleukin-12 Followed by Interferon-Alpha |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | recombinant interferon alfa, recombinant interleukin-12 |
| Enrollment | 40 |
| Start date | Aug 1, 1998 |
| Primary completion | Dec 1, 2001 |
| First posted | Sep 13, 2004 |
| Last update posted | Feb 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: